Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
letter
. 2005 May;64(5):788–789. doi: 10.1136/ard.2004.031187

Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy

D Wendling, B Auge, D Bettinger, A Lohse, G Le Huede, S Bresson-Hadni, E Toussirot, J Miguet, G Herbein, M Di
PMCID: PMC1755487  PMID: 15834064

Full Text

The Full Text of this article is available as a PDF (57.1 KB).

Figure 1.

Figure 1

 Outcome of serum HBV DNA (black squares) expressed in log copies per millilitre, and serum ALT (white circles), expressed in times over the upper limit of normal range (ULN). Serum HBV DNA was quantified using an in-house real time polymerase chain reaction (TaqMan) with primers and probe located in the core region and conserved among HBV genotypes.


Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES